Epigenetic reprogramming in mammalian development - PubMed (original) (raw)
Review
. 2001 Aug 10;293(5532):1089-93.
doi: 10.1126/science.1063443.
Affiliations
- PMID: 11498579
- DOI: 10.1126/science.1063443
Review
Epigenetic reprogramming in mammalian development
W Reik et al. Science. 2001.
Abstract
DNA methylation is a major epigenetic modification of the genome that regulates crucial aspects of its function. Genomic methylation patterns in somatic differentiated cells are generally stable and heritable. However, in mammals there are at least two developmental periods-in germ cells and in preimplantation embryos-in which methylation patterns are reprogrammed genome wide, generating cells with a broad developmental potential. Epigenetic reprogramming in germ cells is critical for imprinting; reprogramming in early embryos also affects imprinting. Reprogramming is likely to have a crucial role in establishing nuclear totipotency in normal development and in cloned animals, and in the erasure of acquired epigenetic information. A role of reprogramming in stem cell differentiation is also envisaged. DNA methylation is one of the best-studied epigenetic modifications of DNA in all unicellular and multicellular organisms. In mammals and other vertebrates, methylation occurs predominantly at the symmetrical dinucleotide CpG (1-4). Symmetrical methylation and the discovery of a DNA methyltransferase that prefers a hemimethylated substrate, Dnmt1 (4), suggested a mechanism by which specific patterns of methylation in the genome could be maintained. Patterns imposed on the genome at defined developmental time points in precursor cells could be maintained by Dnmt1, and would lead to predetermined programs of gene expression during development in descendants of the precursor cells (5, 6). This provided a means to explain how patterns of differentiation could be maintained by populations of cells. In addition, specific demethylation events in differentiated tissues could then lead to further changes in gene expression as needed. Neat and convincing as this model is, it is still largely unsubstantiated. While effects of methylation on expression of specific genes, particularly imprinted ones (7) and some retrotransposons (8), have been demonstrated in vivo, it is still unclear whether or not methylation is involved in the control of gene expression during normal development (9-13). Although enzymes have been identified that can methylate DNA de novo (Dnmt3a and Dnmt3b) (14), it is unknown how specific patterns of methylation are established in the genome. Mechanisms for active demethylation have been suggested, but no enzymes have been identified that carry out this function in vivo (15-17). Genomewide alterations in methylation-brought about, for example, by knockouts of the methylase genes-result in embryo lethality or developmental defects, but the basis for abnormal development still remains to be discovered (7, 14). What is clear, however, is that in mammals there are developmental periods of genomewide reprogramming of methylation patterns in vivo. Typically, a substantial part of the genome is demethylated, and after some time remethylated, in a cell- or tissue-specific pattern. The developmental dynamics of these reprogramming events, as well as some of the enzymatic mechanisms involved and the biological purposes, are beginning to be understood. Here we look at what is known about reprogramming in mammals and discuss how it might relate to developmental potency and imprinting.
Similar articles
- Epigenetic reprogramming in plant and animal development.
Feng S, Jacobsen SE, Reik W. Feng S, et al. Science. 2010 Oct 29;330(6004):622-7. doi: 10.1126/science.1190614. Science. 2010. PMID: 21030646 Free PMC article. Review. - Nuclear cloning and epigenetic reprogramming of the genome.
Rideout WM 3rd, Eggan K, Jaenisch R. Rideout WM 3rd, et al. Science. 2001 Aug 10;293(5532):1093-8. doi: 10.1126/science.1063206. Science. 2001. PMID: 11498580 Review. - DNA methylation and mammalian epigenetics.
Reik W, Dean W. Reik W, et al. Electrophoresis. 2001 Aug;22(14):2838-43. doi: 10.1002/1522-2683(200108)22:14<2838::AID-ELPS2838>3.0.CO;2-M. Electrophoresis. 2001. PMID: 11565778 Review. - DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos.
Messerschmidt DM, Knowles BB, Solter D. Messerschmidt DM, et al. Genes Dev. 2014 Apr 15;28(8):812-28. doi: 10.1101/gad.234294.113. Genes Dev. 2014. PMID: 24736841 Free PMC article. Review. - Epigenetic reprogramming in mammals.
Morgan HD, Santos F, Green K, Dean W, Reik W. Morgan HD, et al. Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R47-58. doi: 10.1093/hmg/ddi114. Hum Mol Genet. 2005. PMID: 15809273 Review.
Cited by
- Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols.
Hu P, Hao Y, Tang W, Diering GH, Zou F, Kafri T. Hu P, et al. bioRxiv [Preprint]. 2024 Aug 31:2024.08.20.608805. doi: 10.1101/2024.08.20.608805. bioRxiv. 2024. PMID: 39229157 Free PMC article. Preprint. - ARID1 is required to regulate and reinforce H3K9me2 in sperm cells in Arabidopsis.
Li L, Yang H, Zhao Y, Hu Q, Zhang X, Jiang T, Jiang H, Zheng B. Li L, et al. Nat Commun. 2024 Aug 16;15(1):7078. doi: 10.1038/s41467-024-51513-4. Nat Commun. 2024. PMID: 39152128 Free PMC article. - Identification of differentially expressed tumour-related genes regulated by UHRF1-driven DNA methylation.
Dong Q, Gong C, Jiang Q, Liu Y, Hu Y, Wang D, Liu H, Zheng T, Song C, Wang T, Ju R, Wang C, Song D, Liu Z, Liu Y, Lu Y, Fan J, Liu M, Gao T, An Z, Zhang J, Li P, Cao C, Liu X. Dong Q, et al. Sci Rep. 2024 Aug 7;14(1):18371. doi: 10.1038/s41598-024-69110-2. Sci Rep. 2024. PMID: 39112494 Free PMC article. - Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease.
Horváth V, Garza R, Jönsson ME, Johansson PA, Adami A, Christoforidou G, Karlsson O, Castilla Vallmanya L, Koutounidou S, Gerdes P, Pandiloski N, Douse CH, Jakobsson J. Horváth V, et al. Nat Struct Mol Biol. 2024 Jun 4. doi: 10.1038/s41594-024-01320-8. Online ahead of print. Nat Struct Mol Biol. 2024. PMID: 38834915 - SETDB1 as a cancer target: challenges and perspectives in drug design.
Hassanie H, Penteado AB, de Almeida LC, Calil RL, da Silva Emery F, Costa-Lotufo LV, Trossini GHG. Hassanie H, et al. RSC Med Chem. 2024 Mar 19;15(5):1424-1451. doi: 10.1039/d3md00366c. eCollection 2024 May 22. RSC Med Chem. 2024. PMID: 38799223 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases